
Femsave 250mg Injection
Marketer
Fem Care Pharma Ltd
Salt Composition
Hydroxyprogesterone (250mg)
Overview Femsave 250mg Injection
To curtail premature labor and the associated risk of preterm delivery in pregnant women, healthcare professionals administer the 250mg Femsave injection. This medication also mitigates the chance of miscarriage, particularly beneficial for women with a prior history of preterm birth. Administration is strictly by, or under the direct guidance of, a physician, who will determine both dosage and treatment duration. Adhere to the prescribed regimen. Frequently reported side effects encompass localized injection site reactions, nausea, pruritus, diarrhea, and skin rashes. Report any persistent or bothersome side effects to your doctor; management strategies may be available. Because Femsave can influence blood glucose levels, regular monitoring is crucial. Immediately inform your physician of any jaundice, dark urine, or abdominal discomfort. Prior to commencing treatment, disclose any pre-existing circulatory issues, diabetes, or hepatic impairment. Furthermore, fully inform your doctor of all other medications currently in use, as potential drug interactions may compromise efficacy or alter the medication's effects.
Uses of Femsave 250mg Injection
Averting Preterm Birth
Major Benefits of Femsave 250mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Femsave 250mg Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Femsave 250mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Femsave 250mg Injection works:
Progestin injection Femsave, 250mg, is a female hormone replacement.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Femsave 250mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Femsave 250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Femsave 250mg Injection is considered safe while breastfeeding. Research in human subjects indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 250mg Femsave injection.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Femsave 250mg Injection to individuals with renal impairment. Physician consultation is advised. This medication's progesterone component may induce fluid retention in patients with pre-existing kidney conditions.
LiverUNSAFE
The use of Femsave 250mg Injection is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.
What if you forget to take Femsave 250mg Injection :
Omitting a scheduled dose of Femsave 250mg Injection warrants immediate physician consultation.
Facts to Know About Femsave 250mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Actions | First-Generation Progestins |
